Delirium, Dementia, Amnestic, Cognitive Disorders  >>  GSK356278  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK356278 / GSK
NCT01573819: A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278

Completed
1
36
Europe
GSK356278, Placebo
GlaxoSmithKline
Huntington Disease
04/12
04/12
NCT01602900: Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease

Completed
1
8
Europe
GSK356278, Rolipram
GlaxoSmithKline
Huntington Disease
04/12
04/12

Download Options